What approved forms or administration methods are available for Femara in cancer therapy?

Femara is approved for cancer therapy in the form of 2.5 mg oral tablets taken once daily, typically used in postmenopausal women with hormone receptor-positive breast cancer.

Overview

Patients researching Femara often want to know the available methods of administration in cancer treatment. It’s important to understand how this medication is formulated and taken to ensure effective use and safety.

• Femara is an oral tablet taken once a day.
• It’s approved primarily for hormone-sensitive breast cancer in postmenopausal women.
• This helps explain why it’s important to follow dosing instructions and monitor for side effects.

Let’s take a closer look at how Femara works and how it supports cancer treatment.

Detailed Information

How it works

Femara may help slow or stop the growth of certain breast cancers by reducing estrogen levels. It works as an aromatase inhibitor, which blocks the enzyme that converts androgens into estrogens, a key hormone in the growth of hormone receptor-positive breast tumors.

Clinical applications

Femara is typically used in postmenopausal women with early breast cancer after surgery or with advanced breast cancer that has spread or returned. According to Drugs.com, it may be used as adjuvant (post-surgery), extended adjuvant, or first-line therapy for metastatic breast cancer.

Safety and Effectiveness

Safety profile

Common side effects include hot flashes, fatigue, joint pain, and increased sweating. According to the patient information leaflet, Femara may also affect bone density, so long-term users may require bone health monitoring by their healthcare provider.

FDA approval and indications

Femara (letrozole) is FDA-approved for specific uses in breast cancer treatment including early, advanced, and metastatic hormone receptor-positive cases. It should only be used under the guidance of a healthcare professional.

Access and Availability

How to obtain safely

Femara requires a prescription and should be acquired from a licensed pharmacy. IsraelPharm offers access to Femara for international patients looking for competitively priced, pharmacy-verified medications. Always talk to your oncologist before starting or switching treatments.

Key Takeaways

• Femara is available as a 2.5 mg oral tablet for daily use.
• It’s used in hormone receptor-positive breast cancer in postmenopausal women.
• The drug works by lowering estrogen levels through aromatase inhibition.
• As with all cancer medications, Femara has potential side effects and requires regular medical supervision.
• Only take Femara if prescribed, and obtain it from a licensed source like IsraelPharm.

FAQ

Is Femara available in any form other than tablets?

No, Femara is approved only as an oral 2.5 mg tablet based on current product information. Other forms are not approved for oncology use.

Can premenopausal women use Femara for cancer therapy?

Femara is approved mainly for postmenopausal women. In rare cases, it may be used alongside ovarian suppression, but only under specialist supervision.

What happens if I miss a dose of Femara?

If a dose is missed, take it as soon as remembered on the same day. Do not double the next dose. Always follow your prescribed schedule.

How long do I need to take Femara?

Duration depends on treatment goals—commonly 5 years, or longer if used as extended adjuvant therapy. Your provider will guide this based on cancer type and recurrence risk.

How much does Femara cost through IsraelPharm?

Pricing may vary depending on quantity and region. You can check pricing and availability directly on the Femara product page at IsraelPharm.